Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Radiation Facility Volume and Survival in Men With Lymph Node-Positive Prostate Cancer Treated With Radiation and Androgen Deprivation Therapy.
Patel SA, Goyal S, Liu Y, Moghanaki D, Patel PR, Hanasoge S, Dhere VR, Shelton JW, Godette KD, Jani AB, Hershatter B, Fischer-Valuck BW. Patel SA, et al. Among authors: hershatter b. JAMA Netw Open. 2020 Dec 1;3(12):e2025143. doi: 10.1001/jamanetworkopen.2020.25143. JAMA Netw Open. 2020. PMID: 33301015 Free PMC article.
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, Pattaras J, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Among authors: hershatter b. Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3. Brachytherapy. 2020. PMID: 32624405
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
Jani A, Schreibmann E, Goyal S, Raghuveer H, Hershatter B, Rossi PJ, Shelton JW, Patel PR, Xu KM, Goodman M, Master V, Joshi SS, Kucuk O, Carthon B, Bilen MA, Cooper S, Fielder B, Abiodun-Ojo O, Dhere VR, Schuster DM. Jani A, et al. Among authors: hershatter b. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1397. doi: 10.1016/j.ijrobp.2020.09.018. Epub 2020 Nov 18. Int J Radiat Oncol Biol Phys. 2020. PMID: 33427655 No abstract available.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Jani AB, Schreibmann E, Goyal S, Halkar R, Hershatter B, Rossi PJ, Shelton JW, Patel PR, Xu KM, Goodman M, Master VA, Joshi SS, Kucuk O, Carthon BC, Bilen MA, Abiodun-Ojo OA, Akintayo AA, Dhere VR, Schuster DM. Jani AB, et al. Among authors: hershatter b. Lancet. 2021 May 22;397(10288):1895-1904. doi: 10.1016/S0140-6736(21)00581-X. Epub 2021 May 7. Lancet. 2021. PMID: 33971152 Free PMC article. Clinical Trial.
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
Dhere VR, Fischer-Valuck BW, Goyal S, Liu Y, Morgan TM, Ghavidel E, Moghanaki DM, Hershatter BW, Patel PR, Jani AB, Godette KD, Rossi PJ, Patel SA. Dhere VR, et al. Among authors: hershatter bw. Brachytherapy. 2021 Nov-Dec;20(6):1130-1138. doi: 10.1016/j.brachy.2021.07.005. Epub 2021 Aug 18. Brachytherapy. 2021. PMID: 34417136
[No title available]
[No authors listed] [No authors listed] PMID: 34701062
[No title available]
[No authors listed] [No authors listed] PMID: 34701063
26 results